학술논문

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
Document Type
Article
Source
In The Lancet Haematology June 2022 9(6):e415-e424
Subject
Primary Research
Articles
Language
ISSN
2352-3026